Shanghai Fosun Pharmaceutical Group Co Ltd
Fosun Pharma's Climate Target Data Preview
As of 2023, Fosun Pharma has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Fosun Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Intensity-based Target | Scope 1 - Total, Scope 2 - Total, Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue | Copy restricted. Please purchase to unlock this data.  | 2025 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Fosun Pharma's Greenhouse Gas Emissions Pathways
As of 2023, Fosun Pharma has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories.
Does Fosun Pharma have a target to reduce its total carbon footprint?
As of 2023, Fosun Pharma has set a target to reduce its total carbon footprint, specifically those from Scope 1, Scope 2 and Scope 3 sources.
Fosun Pharma's most ambitious carbon footprint target is to reduce its scope 1, 2 and 3 emissions from a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2020, by 15% by 2025.
As of 2023, Fosun Pharma is ahead of schedule on its total carbon footprint reduction target, having achieved 91.33% of the planned reduction.